A detailed history of Darwin Global Management, Ltd. transactions in Geron Corp stock. As of the latest transaction made, Darwin Global Management, Ltd. holds 22,038,773 shares of GERN stock, worth $89 Million. This represents 8.14% of its overall portfolio holdings.

Number of Shares
22,038,773
Previous 23,915,480 7.85%
Holding current value
$89 Million
Previous $101 Million 1.33%
% of portfolio
8.14%
Previous 12.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.17 - $4.99 $7.83 Million - $9.36 Million
-1,876,707 Reduced 7.85%
22,038,773 $100 Million
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $74.1 Million - $122 Million
23,915,480 New
23,915,480 $101 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.53B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Darwin Global Management, Ltd. Portfolio

Follow Darwin Global Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Darwin Global Management, Ltd. with notifications on news.